Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features

@inproceedings{Peng2013DifferentialEO,
  title={Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features},
  author={Jie Peng and Ali Kord Valeshabad and Qingfu Li and Yuan Wang},
  booktitle={Oncology letters},
  year={2013}
}
RNA binding motif 5 (RBM5) is a tumor suppressor gene that regulates cell proliferation, differentiation and apoptosis through pre-mRNA splicing of related genes. This study aimed to detect RBM5 and KRAS expression in pancreatic ductal adenocarcinoma and their association with clinicopathological features. Detection of RBM5 and KRAS expression by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting was performed at mRNA and protein levels, respectively, in… CONTINUE READING